A familial generalized pediatric epilepsy, characterized by very frequent (multiple per day) absence seizures, usually occurring in children between the ages of 4 and 10 years, with, in most cases, a ...
Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation about childhood absence epilepsy is limited due to its relatively rare occurrence and the variability in clinical presentation among affected individuals. The genetic basis, while partially understood, is still being explored, which contributes to the gaps in systematic clinical studies. This means that while some information is available, comprehensive data on all aspects of the condition is still evolving.
To navigate childhood absence epilepsy effectively, seek a pediatric neurologist with expertise in epilepsy, particularly one familiar with genetic factors. While there are currently no specific patient organizations identified for this condition, resources such as the National Organization for Rare Disorders (NORD) at rarediseases.org can provide valuable support. Additionally, consider looking into genetic counseling, especially given the involvement of the GABRG2 gene, which may help inform family planning and management strategies.
Research is ongoing in the field of childhood absence epilepsy, with three orphan drugs designated for development: brivaracetam, cannabidiol, and flunarizine. Currently, there are five active clinical trials investigating various aspects of the condition. For further information on these trials, you can visit the ClinicalTrials.gov search page at https://clinicaltrials.gov/search?cond=childhood%20absence%20epilepsy. This research offers hope for improved treatments and understanding of the condition.
Actionable guidance for navigating care for childhood absence epilepsy
To navigate childhood absence epilepsy effectively, seek a pediatric neurologist with expertise in epilepsy, particularly one familiar with genetic factors. While there are currently no specific patient organizations identified for this condition, resources such as the National Organization for Rare Disorders (NORD) at rarediseases.org can provide valuable support. Additionally, consider looking into genetic counseling, especially given the involvement of the GABRG2 gene, which may help inform family planning and management strategies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease